Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

12-Month Reliance Complete Service Contract

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

811212 - Computer and Office Machine Repair and MaintenanceView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Comprehensive maintenance and support agreement covering preventive maintenance, technical support, and repairs for the BioMicroLab VC384 system over 12 months.

Similar Contracts

Same NAICS industry code

NAICS: 811212
New
Federal
Maintenance & Lifecycle Support PlanThe contract titled Maintenance & Lifecycle Support Plan outlines a comprehensive service agreement to ensure the continued operational integrity of a critical system through preventive maintenance, troubleshooting, and one dedicated on-site technician visit for a system health check. The provider is expected to deliver proactive care to minimize downtime, identify potential failures before they occur, and resolve issues efficiently when they arise, maintaining system reliability over its operational lifecycle. The on-site visit is a key component designed to allow direct assessment of hardware, software, and environmental conditions, ensuring that the system performs optimally under real-world conditions. This subcontract, categorized under NAICS code 811212, is issued by the Department of Defense through its DCSO-COLUMBUS-DIVISION-2 office and is performance-based in Philadelphia with a zip code of 19111. The opportunity was posted on August 4, 2026, and responses are due by August 18, 2026, at 4:00 PM. There is no set-aside designation specified, and the contract does not include details on point of contact information. All work must be executed in compliance with the Department of Defense’s requirements for system sustainment and readiness, with the goal of extending service life, reducing repair costs, and maintaining mission-critical capabilities.
DCSO-COLUMBUS-DIVISION-2

POSTED

1 day ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 424690
New
Federal
Supply of Research Reagents and DietsThe contract entails the supply of specialized research reagents and diets essential for preclinical disease modeling, including adenine-enriched diets, high-sucrose and high-fat diets, streptozotocin, and associated ancillary reagents required to induce and maintain metabolic and renal disease models in animal studies. These materials are critical for supporting biomedical research aimed at understanding chronic conditions such as diabetes, kidney disease, and metabolic syndrome under controlled experimental conditions. The reagents must meet strict quality and consistency standards to ensure reproducibility and validity of research outcomes across multiple investigative sites. This subcontract, issued under the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 424690 for medical and dental equipment and supplies merchant wholesalers. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. Performance is expected to support research activities managed by federal entities, though specific locations for delivery or use are not detailed. Suppliers must be prepared to comply with federal procurement requirements, deliver reagents in appropriate formulations and quantities, and ensure traceability and documentation for all provided items to facilitate regulatory and scientific compliance.
Other Chemical and Allied Products Merchant Wholesalers

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541690
New
Federal
Efficacy Study – HSHFD+STZ-Induced Diabetic Kidney Disease ModelThe contract outlines a commissioned efficacy study to evaluate the impact of an NNMT inhibitor in a mouse model of diabetic kidney disease induced by a high-sodium, high-fat diet combined with streptozotocin. The study requires comprehensive metabolic monitoring throughout the treatment period, precise dosing regimens, and systematic collection of tissue samples for downstream analysis. Endpoint evaluation will include detailed assessment of renal function, histopathological changes, and molecular markers associated with disease progression and therapeutic response. All procedures must adhere to standardized protocols to ensure data reliability and reproducibility, with results intended to support further development of the inhibitor as a potential therapeutic agent. The work is being pursued under a subcontract agreement issued by the National Institutes of Health through the Department of Health and Human Services, classified under NAICS code 541690 for other scientific research and development services. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. The contract does not specify a place of performance or point of contact, and no set-aside provisions are indicated. The project is positioned as a critical preclinical step in advancing an NNMT-targeted intervention for diabetic kidney disease, with findings expected to inform future clinical translation and funding decisions.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Evaluation of a Lead NNMT Inhibitor in Humanized M
Solicitation # 75N98026Q00941
The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 325413
New
Federal
Fisher Scientific Reagents and Consumable Materials for Cell Therapy Manufacturing
Solicitation # 26-008155
The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to Fisher Scientific for validated reagents and consumable materials essential to the manufacturing of FDA-regulated cell-based therapies used in NIH clinical trials. These materials have been rigorously validated and approved by the Center for Cellular Engineering’s Quality Assurance Department to ensure consistent quality, safety, and efficacy in producing cell therapies for patient care. Any substitution of these materials would necessitate extensive and costly revalidation of manufacturing processes, leading to significant delays and potential risks to ongoing clinical trials, making Fisher Scientific the only viable supplier capable of providing the required validated products and supporting documentation compliant with federal regulatory standards. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which allows for single-source procurement when only one provider can meet the government’s specific requirements, and the value does not exceed the simplified acquisition threshold. The product service code is 6550, and the NAICS code is 325413, classifying the items as in-vitro diagnostic substances. Performance will occur at the NIH Clinical Center in Bethesda, Maryland. While this notice does not solicit bids or proposals, responsible parties may submit capability statements by August 13, 2026, at 6:00 p.m. Eastern Time, referencing POTS 26-008155, though the government retains full discretion to proceed without competition. All inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.
In-Vitro Diagnostic Substance Manufacturing

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 811210
New
Federal
Annual Service and Maintenance Agreement for Agile
Solicitation # 75N98026Q00944
The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking proposals under solicitation number 75N98026Q00944 for an Annual Service and Maintenance Agreement for Agile, issued as a competitive combined synopsis and solicitation under FAR Subpart 12.6 for commercial items. The contract will be awarded on a firm-fixed-price basis to the offeror providing the best value to the government through full and open competition, with no set-aside restrictions, and the requirement is not expected to exceed the simplified acquisition threshold. The solicitation is governed by provisions and clauses in effect through the Federal Acquisition Circular effective August 3, 2026, and the North American Industry Classification System code is 811210, corresponding to Electronic and Precision Equipment Repair and Maintenance, with a small business size standard of $34.0 million in annual revenue. Proposals must be submitted by August 19, 2026, at 8:00 PM Eastern Time, following the instructions outlined in the solicitation document, which serves as the complete request for offers without a separate written solicitation. The place of performance and specific delivery details are not fully defined in the posting, but the contracting office is located in Bethesda, Maryland. All inquiries should be directed to John Johnston, the primary point of contact, reached at jaddua.johnston@nih.gov. The solicitation is accessible online through the SAM.gov portal, and offerors are expected to review all applicable terms and conditions prior to submission.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 14 days
View Details